rs28399504

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PVS1_SupportingBS2

The NM_000769.4(CYP2C19):​c.1A>G​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0024 in 1,613,130 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (★★★★).

Frequency

Genomes: 𝑓 0.0024 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0024 ( 14 hom. )

Consequence

CYP2C19
NM_000769.4 start_lost

Scores

6
10

Clinical Significance

drug response practice guideline B:1O:3

Conservation

PhyloP100: 0.495

Publications

182 publications found
Variant links:
Genes affected
CYP2C19 (HGNC:2621): (cytochrome P450 family 2 subfamily C member 19) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PVS1
Start lost variant, no pathogenic variants between lost start and next in-frame start position. Next in-frame start position is after 74 codons. Genomic position: 94775109. Lost 0.149 part of the original CDS.
BS2
High AC in GnomAd4 at 362 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2C19NM_000769.4 linkc.1A>G p.Met1? start_lost Exon 1 of 9 ENST00000371321.9 NP_000760.1 P33261

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2C19ENST00000371321.9 linkc.1A>G p.Met1? start_lost Exon 1 of 9 1 NM_000769.4 ENSP00000360372.3 P33261
CYP2C19ENST00000480405.2 linkc.1A>G p.Met1? start_lost Exon 1 of 3 1 ENSP00000483847.1 A0A087X125
ENSG00000276490ENST00000464755.1 linkn.932-12352A>G intron_variant Intron 6 of 13 2 ENSP00000483243.1 A0A087X0B3

Frequencies

GnomAD3 genomes
AF:
0.00238
AC:
362
AN:
152162
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00647
Gnomad ASJ
AF:
0.0158
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0000946
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00256
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00233
AC:
585
AN:
251032
AF XY:
0.00226
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.00287
Gnomad ASJ exome
AF:
0.0162
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00251
Gnomad OTH exome
AF:
0.00278
GnomAD4 exome
AF:
0.00240
AC:
3504
AN:
1460850
Hom.:
14
Cov.:
30
AF XY:
0.00243
AC XY:
1769
AN XY:
726674
show subpopulations
African (AFR)
AF:
0.000419
AC:
14
AN:
33450
American (AMR)
AF:
0.00286
AC:
128
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.0164
AC:
428
AN:
26092
East Asian (EAS)
AF:
0.000252
AC:
10
AN:
39678
South Asian (SAS)
AF:
0.000290
AC:
25
AN:
86204
European-Finnish (FIN)
AF:
0.0000562
AC:
3
AN:
53352
Middle Eastern (MID)
AF:
0.00110
AC:
6
AN:
5464
European-Non Finnish (NFE)
AF:
0.00244
AC:
2712
AN:
1111568
Other (OTH)
AF:
0.00295
AC:
178
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
170
339
509
678
848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00238
AC:
362
AN:
152280
Hom.:
2
Cov.:
33
AF XY:
0.00267
AC XY:
199
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.000553
AC:
23
AN:
41588
American (AMR)
AF:
0.00647
AC:
99
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0158
AC:
55
AN:
3472
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5180
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4822
European-Finnish (FIN)
AF:
0.0000946
AC:
1
AN:
10568
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00256
AC:
174
AN:
68018
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00286
Hom.:
11
Bravo
AF:
0.00247
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00326
AC:
28
ExAC
AF:
0.00189
AC:
229
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00218
EpiControl
AF:
0.00279

ClinVar

Significance: drug response
Submissions summary: Benign:1Other:3
Revision: practice guideline
LINK: link

Submissions by phenotype

not provided Benign:1Other:1
Mar 26, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Dec 28, 2015
Eurofins Ntd Llc (ga)
Significance:other
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- Variant classified as "other reportable" ??? variant is clinically benign (not associated with disease) but is reported when observed (e.g. pseudodeficiency alleles).

Mephenytoin, poor metabolism of Other:1
Jan 01, 1998
OMIM
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:literature only

- -

CYP2C19: no function Other:1
-
Clinical Pharmacogenetics Implementation Consortium
Significance:drug response
Review Status:practice guideline
Collection Method:curation

- Allele function

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
15
DANN
Benign
0.79
DEOGEN2
Benign
0.062
T;.
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.17
N
LIST_S2
Uncertain
0.90
D;.
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.014
T;T
MetaSVM
Benign
-0.70
T
PhyloP100
0.49
PROVEAN
Uncertain
-3.4
.;D
REVEL
Uncertain
0.31
Sift
Uncertain
0.0010
.;D
Sift4G
Uncertain
0.016
D;D
Vest4
0.49
MVP
0.61
ClinPred
0.060
T
GERP RS
1.8
PromoterAI
0.047
Neutral
gMVP
0.33
Mutation Taster
=114/86
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28399504; hg19: chr10-96522463; API